Conclusion Beyond their metabolic effects, Semaglutide and Tirzepatide anti-inflammatory properties suggest potential therapeutic applications in conditions characterized by chronic inflammation, such as cardiovascular diseases, neurodegenerative disorders, bone degenerative disease and autoimmune conditions. These peptides could be considered as potential anti-aging agents. ----------------------------------------------------------------------------------------------------------------------------- Important Warning In addendum to the information above, Dr
Most patients begin with the lowest therapeutic dose and gradually increase over 4-12 weeks as their body adjusts
A recent paper published in The Lancet showed that nearly 20% of participants in lifestyle interventions without medications gain weight, around 40% lose between 1-10% of their body weight, and just 13% lose more than 10%
95% CI, 1.242.47) and fewer had episodes of major depression (HR, 0.71
Photo: Tirachardz
Introduction Finding a rhythm with a new weight loss medication is a significant milestone, but it can be unsettling when your body reacts in unexpected ways